Theo ER · DIN 02360101 · 400 mg · extended release tablet
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Theo ER · DIN 02360101
Manufacturer: A A Pharma Inc.; listing date 2014-01-03
Health Canada: Marketed since 2011-06-23 · brand THEO ER · ATC R03DA04 THEOPHYLLINE · form Tablet (extended-release) · route Oral · ingredients THEOPHYLLINE 400 MG · company Aa pharma inc · schedule Prescription
Ministry pays: $0.3734 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02360101)
Source record
DIN 02360101: Theo ER
Raw flags: sec3=Y
Item: 860000046; group id 878; item number 2119; lccId None; manufacturer id AAP
Source form: SR Tab; strength: 400mg
Recorded listing: General benefit
Source prices (unrounded): $0.3735; ministry $0.3734
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02360101
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=84507
Interchangeable products
Uniphyl · DIN 02014165 · not recorded
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02360101
Shortage record checked October 6, 2026